Showing results (51-60 of 246) with videos related to
Sort By:
Pageof 25
JAMA Network Open|January 16, 2019
Association of Fatality Risk With Value-Based Drug Pricing of Epinephrine Autoinjectors for Children With Peanut Allergy: A Cost-effectiveness AnalysisMarcus Shaker, Matthew GreenhawtAllergy and Asthma Proceedings|September 14, 2019
Peanut allergy: Burden of illnessMarcus Shaker, Matthew GreenhawtAnnals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 26, 2019
Providing cost-effective care for food allergyMarcus Shaker, Matthew GreenhawtCurrent Opinion in Pediatrics|August 5, 2010
More than just infections: an update on primary immune deficienciesCorinne Savides, Marcus ShakerJAMA Network Open|December 21, 2019
Determining Levers of Cost-effectiveness for Screening Infants at High Risk for Peanut Sensitization Before Early Peanut IntroductionMatthew Greenhawt, Marcus ShakerJAMA Network Open|May 4, 2019
Estimation of Health and Economic Benefits of Commercial Peanut Immunotherapy Products: A Cost-effectiveness AnalysisMarcus Shaker, Matthew GreenhawtCurrent Opinion in Pediatrics|September 1, 2012
An update on hereditary angioedemaDerek Hsu, Marcus ShakerAnnals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 26, 2019
A primer on cost-effectiveness in the allergy clinicMarcus Shaker, Matthew GreenhawtThe Journal of Allergy and Clinical Immunology. in Practice|May 12, 2018
The Health and Economic Outcomes of Peanut Allergy Management PracticesMarcus Shaker, Matthew GreenhawtCurrent Opinion in Allergy and Clinical Immunology|August 5, 2016
An update on ocular allergyMarcus Shaker, Erin SalconePageof 25